Wedbush Securities Inc. boosted its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 22.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,850 shares of the medical research company’s stock after buying an additional 517 shares during the quarter. Wedbush Securities Inc.’s holdings in Thermo Fisher Scientific were worth $497,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the stock. Sharkey Howes & Javer raised its holdings in Thermo Fisher Scientific by 1.0% during the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after buying an additional 7 shares during the last quarter. Beacon Trust Co. raised its holdings in Thermo Fisher Scientific by 0.6% during the 1st quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock valued at $341,000 after buying an additional 12 shares during the last quarter. Dumont & Blake Investment Advisors LLC raised its holdings in Thermo Fisher Scientific by 0.3% during the 1st quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock valued at $849,000 after buying an additional 15 shares during the last quarter. Reinhart Partners Inc. raised its holdings in Thermo Fisher Scientific by 0.6% during the 2nd quarter. Reinhart Partners Inc. now owns 3,430 shares of the medical research company’s stock valued at $598,000 after buying an additional 20 shares during the last quarter. Finally, Azimuth Capital Management LLC raised its holdings in Thermo Fisher Scientific by 0.8% during the 1st quarter. Azimuth Capital Management LLC now owns 3,210 shares of the medical research company’s stock valued at $493,000 after buying an additional 25 shares during the last quarter. Institutional investors own 83.36% of the company’s stock.

In related news, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the sale, the director now directly owns 38,757 shares in the company, valued at $6,702,635.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at $961,312.64. The disclosure for this sale can be found here. Insiders sold 22,738 shares of company stock valued at $4,021,512 over the last 90 days. 0.49% of the stock is currently owned by corporate insiders.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at 187.91 on Friday. The stock has a market capitalization of $73.31 billion, a P/E ratio of 32.74 and a beta of 1.05. The stock has a 50 day moving average of $181.07 and a 200-day moving average of $171.15. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period last year, the company earned $2.03 earnings per share. Analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

ILLEGAL ACTIVITY NOTICE: “Thermo Fisher Scientific Inc (TMO) Position Raised by Wedbush Securities Inc.” was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-position-raised-by-wedbush-securities-inc/1579316.html.

A number of equities research analysts recently commented on TMO shares. Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Saturday, June 10th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Citigroup Inc. reiterated a “buy” rating and set a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price target for the company in a report on Tuesday, July 11th. Finally, Wells Fargo & Company reiterated an “outperform” rating and set a $200.00 price target (up from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 13th. One investment analyst has rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. Thermo Fisher Scientific has a consensus rating of “Buy” and an average target price of $193.44.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.